{
    "organizations": [],
    "uuid": "3f690692fb9960745e50b6b2ca83cb8c73d7bd67",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aetion-announces-36-mln-in-series/brief-aetion-announces-36-mln-in-series-b-funding-idUSASC09VI1",
    "ord_in_thread": 0,
    "title": "BRIEF-Aetion Announces $36 Mln In Series B Funding",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11 (Reuters) - Aetion:\n* ANNOUNCES $36 MILLION IN SERIES B FUNDING TO ACCELERATE ITS PLATFORM FOR THE ANALYSIS OF REAL WORLD EVIDENCE TO BIOPHARMA COMPANIES AND HEALTH CARE PAYERS\n* AETION SAYS IT HAS RAISED $36.4 MILLION IN SERIES B FUNDING. ROUND WAS LED BY NEW ENTERPRISE ASSOCIATES Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-11T18:32:00.000+03:00",
    "crawled": "2018-04-12T14:21:16.078+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "aetion",
        "announces",
        "million",
        "series",
        "b",
        "funding",
        "accelerate",
        "platform",
        "analysis",
        "real",
        "world",
        "evidence",
        "biopharma",
        "company",
        "health",
        "care",
        "payer",
        "aetion",
        "say",
        "raised",
        "million",
        "series",
        "b",
        "funding",
        "round",
        "led",
        "new",
        "enterprise",
        "associate",
        "source",
        "text",
        "eikon"
    ]
}